under the microscope

A single vaccine for all 20 influenza subtypes.

Most of us are familiar with the annual flu vaccine that targets a few strains that are expected to be most prevalent. “But what is particularly unique, and potentially controversial, about this new 20-strain mRNA vaccine is its targeting of […]

to your health

mRNA vaccine technology moves to flu.

This is still only the beginning. “Moderna has given out the first doses of an mRNA-based influenza vaccine to participants in an early-phase clinical trial, the company announced Wednesday.” | learn more